We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.95%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$148B
AUM Growth
+$13.7B
Cap. Flow
+$2.5B
Cap. Flow %
1.69%
Top 10 Hldgs %
25.2%
Holding
4,104
New
267
Increased
1,933
Reduced
1,554
Closed
192

Top Buys

Rank Stock Value
1
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$292M
2
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$253M
3
VIG icon
Vanguard Dividend Appreciation ETF
VIG
+$230M
4
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$156M
5
DXCM icon
DexCom
DXCM
+$107M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$233M
2
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$137M
3
NVDA icon
NVIDIA
NVDA
+$115M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$89.9M
5
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$85.1M

Sector Composition

Rank Sector Weight
1 Technology 16.03%
2 Financials 9.11%
3 Healthcare 8.03%
4 Industrials 6.97%
5 Consumer Discretionary 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABCL icon
3776
AbCellera Biologics
ABCL
$2.99B
$61.9K ﹤0.01%
13,674
+1,288
+10% +$6.57K
NAT icon
3777
Nordic American Tanker
NAT
$1.31B
$61K ﹤0.01%
+15,555
New +$65.3K
NEXI
3778
DELISTED
NexImmune, Inc. Common Stock
NEXI
$60.6K ﹤0.01%
+10,804
New +$83.2K
SPWR
3779
DELISTED
SunPower Corporation Common Stock
SPWR
$60.5K ﹤0.01%
20,158
-13,106
-39% -$43.2K
KRMD icon
3780
KORU Medical Systems
KRMD
$159M
$60.4K ﹤0.01%
+25,600
New +$54.9K
OXSQ icon
3781
Oxford Square Capital
OXSQ
$155M
$58.5K ﹤0.01%
18,464
+42
+0.2% +$128
HIMX
3782
Himax Technologies
HIMX
$2.61B
$58.4K ﹤0.01%
+10,918
New +$62.4K
OPFI icon
3783
OppFi
OPFI
$562M
$56.1K ﹤0.01%
22,426
+9,689
+76% +$32.9K
TDAY
3784
USA Today Co
TDAY
$1B
$56K ﹤0.01%
22,949
-31
-0.1% -$70
EDF
3785
Virtus Stone Harbor Emerging Markets Income Fund
EDF
$170M
$56K ﹤0.01%
10,343
– –
ANIX icon
3786
Anixa Biosciences
ANIX
$110M
$55.4K ﹤0.01%
17,755
-37,894
-68% -$151K
PDSB icon
3787
PDS Biotechnology
PDSB
$14.4M
$54.9K ﹤0.01%
13,852
-10,509
-43% -$54.1K
PRTS icon
3788
CarParts.com
PRTS
$51.3M
$54.8K ﹤0.01%
3,381
-20
-0.6% -$501
SAVE
3789
DELISTED
Spirit Airlines, Inc.
SAVE
$53.4K ﹤0.01%
+11,035
New +$81.6K
MTTR
3790
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$52.6K ﹤0.01%
23,260
-240,902
-91% -$528K
BTAI icon
3791
BioXcel Therapeutics
BTAI
$28.8M
$52.3K ﹤0.01%
1,158
-26
-2% -$1.24K
SLQT icon
3792
SelectQuote
SLQT
$122M
$52K ﹤0.01%
26,000
– –
BE icon
3793
CALL
Bloom Energy
BE
$62.2B
$50K ﹤0.01%
5,000
-33,200
-87% -$365K
TOON icon
3794
Kartoon Studios
TOON
$35.4M
$49.9K ﹤0.01%
36,441
– –
SCLX icon
3795
Scilex Holding
SCLX
$47.2M
$49.7K ﹤0.01%
893
+2
+0.2% +$117
LAB icon
3796
Standard BioTools
LAB
$309M
$49.3K ﹤0.01%
+18,194
New +$43.9K
SKIN icon
3797
SkinHealth Systems
SKIN
$91.1M
$49K ﹤0.01%
11,044
+1,000
+10% +$3.25K
LX
3798
LexinFintech Holdings
LX
$242M
$48.5K ﹤0.01%
26,947
+15,000
+126% +$27.8K
EVGO icon
3799
EVgo
EVGO
$503M
$47.9K ﹤0.01%
19,081
-3,675
-16% -$9.54K
CTSO icon
3800
Cytosorbents Corp
CTSO
$22.6M
$47.5K ﹤0.01%
50,000
– –
150 151
152
153 154

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q1 2024 Portfolio in Review

As of Q1 2024, Raymond James & Associates held 4,104 positions worth $148B, up 10% from $134B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q1 2024 filing shows 267 new, 1,933 increased, 1,554 reduced and 192 closed positions. Its largest new stake was Veralto: 431,115 shares worth $38.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $233M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q1 2024 buy was Veralto: 431,115 shares worth $38.2M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q1 2024, an estimated $292M increase.
  • Raymond James & Associates's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $233M.
  • Raymond James & Associates fully exited Splunk Inc in Q1 2024, selling an estimated $14.6M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $148B portfolio in Q1 2024.
  • Raymond James & Associates opened 267 new positions and closed 192 in Q1 2024.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $148B.

Based on Raymond James & Associates's 13F filing for Q1 2024, filed 22 Apr 2024.